← All stocks

Glucotrack, Inc.

GCTK Net buying
CIK 0001506983 #5509 in the set updated 21 Sep 2026
Bought (120 mo)
$230.00K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$230.00K
+$230.00K against sales at will

By person

11 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SYCOFF DREW
Director
$230.00K (1)
+$230.00K
2,951,258
$3.72M
+6.6%
BALLANTYNE JOHN
Director
2,747,717
$3.46M
+5,287%
John A. Ballantyne Revocable Living Trust dated 08/01/2017 entity
10% owner
2,743,591
$3.46M
+5,279%
BOYDSTON ANGELA STRAND
Interim Chief Strategy Officer
17,779
$22.40K
Balo Andrew K
Director
4,692
$5.91K
Malave Luis
Director
4,058
$5.11K
Seff Leslie
Director
3,334
$4.20K
Carter Erin Catherine
Director
2,148
$2.71K
Fischell Robert
Director
2,045
$2.58K
Danzig Allen
Director
1,922
$2.42K
+1,173%
Goode Paul
Chief Executive Officer
339
$427.14

No percentages here. This company's share count has moved by a factor of 28.4 over the window, from 899,410 to 25,585,853 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Goode Paul
14 Nov 2024
Chief Executive Officer
Exercised, kept
796
$31.20
$24.84K
Carter Erin Catherine
14 Nov 2024
Director
Exercised, kept
2,078
$31.20
$64.83K
Malave Luis
14 Nov 2024
Director
Exercised, kept
6,886
$31.20
$214.84K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 5,633,553
History held since 15 Nov 2016